Search research articles
Contact Us
Filters
Showing results (211-220 of 253) with videos related to
Page
of 26
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2021
A Randomized Phase II Study of Androgen Deprivation Therapy with or without Palbociclib in RB-positive Metastatic Hormone-Sensitive Prostate Cancer
Phillip L Palmbos, Stephanie Daignault-Newton, Scott A Tomlins, et al.
International Journal of Molecular Sciences
|
November 11, 2022
Characterization of BCMA Expression in Circulating Rare Single Cells of Patients with Plasma Cell Neoplasms
Libere J Ndacayisaba, Kate E Rappard, Stephanie N Shishido, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2005
Pilot trial of unlabeled and indium-111-labeled anti-prostate-specific membrane antigen antibody J591 for castrate metastatic prostate cancer
Michael J Morris, Chaitanya R Divgi, Neeta Pandit-Taskar, et al.
British Journal of Haematology
|
August 3, 2021
Fimepinostat (CUDC-907) in patients with relapsed/refractory diffuse large B cell and high-grade B-cell lymphoma: report of a phase 2 trial and exploratory biomarker analyses
Daniel J Landsburg, Stefan K Barta, Radhakrishnan Ramchandren, et al.
European Urology
|
August 7, 2025
Pathogenic Genomic Alterations in Circulating Tumor DNA Predict Overall Survival in Men with Metastatic Castrate-resistant Prostate Cancer
Susan Halabi, Siyuan Guo, Bin Luo, et al.
European Urology
|
October 21, 2018
Genomic Analysis of Three Metastatic Prostate Cancer Patients with Exceptional Responses to Carboplatin Indicating Different Types of DNA Repair Deficiency
Zafeiris Zafeiriou, Diletta Bianchini, Robert Chandler, et al.
Leukemia & Lymphoma
|
October 3, 2018
Obinutuzumab plus CHOP is effective and has a tolerable safety profile in previously untreated, advanced diffuse large B-cell lymphoma: the phase II GATHER study
Jeff P Sharman, Andres Forero-Torres, Luciano J Costa, et al.
Molecular Cancer Research : MCR
|
April 27, 2025
Exploring STEAP1 Expression in Prostate Cancer Cells in Response to Androgen Deprivation and in Small Extracellular Vesicles
Candice L Bizzaro, Camila A Bach, Ricardo A Santos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 10, 2018
MAPK Reliance via Acquired CDK4/6 Inhibitor Resistance in Cancer
Renée de Leeuw, Christopher McNair, Matthew J Schiewer, et al.
Current Oncology (Toronto, Ont.)
|
May 27, 2022
Enrichment-Free Single-Cell Detection and Morphogenomic Profiling of Myeloma Patient Samples to Delineate Circulating Rare Plasma Cell Clones
Libere J Ndacayisaba, Kate E Rappard, Stephanie N Shishido, et al.
Page
of 26
Search research articles
Search
Showing results (211-220 of 253) with videos related to
Sort By:
Page
of 26
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2021
A Randomized Phase II Study of Androgen Deprivation Therapy with or without Palbociclib in RB-positive Metastatic Hormone-Sensitive Prostate Cancer
Phillip L Palmbos, Stephanie Daignault-Newton, Scott A Tomlins, et al.
International Journal of Molecular Sciences
|
November 11, 2022
Characterization of BCMA Expression in Circulating Rare Single Cells of Patients with Plasma Cell Neoplasms
Libere J Ndacayisaba, Kate E Rappard, Stephanie N Shishido, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2005
Pilot trial of unlabeled and indium-111-labeled anti-prostate-specific membrane antigen antibody J591 for castrate metastatic prostate cancer
Michael J Morris, Chaitanya R Divgi, Neeta Pandit-Taskar, et al.
British Journal of Haematology
|
August 3, 2021
Fimepinostat (CUDC-907) in patients with relapsed/refractory diffuse large B cell and high-grade B-cell lymphoma: report of a phase 2 trial and exploratory biomarker analyses
Daniel J Landsburg, Stefan K Barta, Radhakrishnan Ramchandren, et al.
European Urology
|
August 7, 2025
Pathogenic Genomic Alterations in Circulating Tumor DNA Predict Overall Survival in Men with Metastatic Castrate-resistant Prostate Cancer
Susan Halabi, Siyuan Guo, Bin Luo, et al.
European Urology
|
October 21, 2018
Genomic Analysis of Three Metastatic Prostate Cancer Patients with Exceptional Responses to Carboplatin Indicating Different Types of DNA Repair Deficiency
Zafeiris Zafeiriou, Diletta Bianchini, Robert Chandler, et al.
Leukemia & Lymphoma
|
October 3, 2018
Obinutuzumab plus CHOP is effective and has a tolerable safety profile in previously untreated, advanced diffuse large B-cell lymphoma: the phase II GATHER study
Jeff P Sharman, Andres Forero-Torres, Luciano J Costa, et al.
Molecular Cancer Research : MCR
|
April 27, 2025
Exploring STEAP1 Expression in Prostate Cancer Cells in Response to Androgen Deprivation and in Small Extracellular Vesicles
Candice L Bizzaro, Camila A Bach, Ricardo A Santos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 10, 2018
MAPK Reliance via Acquired CDK4/6 Inhibitor Resistance in Cancer
Renée de Leeuw, Christopher McNair, Matthew J Schiewer, et al.
Current Oncology (Toronto, Ont.)
|
May 27, 2022
Enrichment-Free Single-Cell Detection and Morphogenomic Profiling of Myeloma Patient Samples to Delineate Circulating Rare Plasma Cell Clones
Libere J Ndacayisaba, Kate E Rappard, Stephanie N Shishido, et al.
Page
of 26